Bursitis, Hypoxia, Arthritis Infective, Dyspnoea, Interstitial Lung Disease, Arthralgia, Localised Infection, Osteoarthritis, Escherichia Infection (7281890-4)
on Feb 03, 2011 Female patient from FRANCE , weighting 180.8 lb, was treated with Co-aprovel(
View Usage). Patient experienced the following unwanted or unexpected effects:
bursitis (What is bursitis?),
hypoxia,
arthritis infective,
dyspnoea,
interstitial lung disease,
arthralgia,
localised infection,
osteoarthritis (What is osteoarthritis?),
escherichia infection. Co-aprovel dosage: N/A. Patient was hospitalized.
Thrombophlebitis (7280540-0)
Patient was taking Co-aprovel (
View Usage). Patient had the following side effects:
thrombophlebitis on Feb 03, 2011 from ALGERIA Additional patient health information: Female patient , 78 years of age, . Co-aprovel dosage: N/A.
Patient was taking other medications:
Thrombophlebitis (7276311-1)
Adverse event was reported on Jan 27, 2011 by a Female patient taking Co-aprovel (
View Usage) (Dosage: N/A) . Location: ALGERIA , 78 years of age, After Co-aprovel was administered, patient had the following side effects:
thrombophlebitis.
Patient was taking other medications: